Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021
Collaboration designed to bring reproductive health screening capabilities to hospitals and clinics across the country
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
This unique record was made possible by collating hard copies of the books in a structured manner
A total of Rs 17,691.08 cr. invested in 157 new approved medical colleges since 2014
With the launch of QurOne, the brand aims to redefine healthcare in the country with seamless, hassle-free patient care and hyper-coordinated workflows
Incidences of Non-alcoholic Fatty Liver Disease (NAFLD) have been rising exponentially worldwide and are associated with co-morbidities including obesity, diabetes, hypertension and metabolic disorders
The company’s wide therapeutic portfolio helped to sustain growth despite changing market demand
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
